These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 2472049

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
    Akimoto S, Akakura K, Shimazaki J.
    Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
    [Abstract] [Full Text] [Related]

  • 23. [Measurements of prostatic acid phosphatase and prostate specific antigen by fully automated enzyme immunoassay system--its analytical and clinical evaluation].
    Matui A, Yamada T, Sugita O, Yakata M.
    Rinsho Byori; 1990 Jun; 38(6):693-8. PubMed ID: 1696328
    [Abstract] [Full Text] [Related]

  • 24. [The clinical significance of serum tissue polypeptide antigen as a tumor marker for urogenital carcinomas--a comparison with other tumor markers in patients with renal cell carcinoma and prostatic carcinoma].
    Yamazaki K, Kumamoto Y, Tsukamoto T, Umehara T, Ohmura K.
    Hinyokika Kiyo; 1987 Oct; 33(10):1581-9. PubMed ID: 2451408
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Tumor markers in prostate cancer].
    Kuriyama M.
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1915-22. PubMed ID: 7521999
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Prostatic cancer developing after transurethral resection of the prostate for benign prostatic hyperplasia].
    Tanaka Y, Aoyama H, Momose H, Ono T, Samma S, Tanaka N, Akiyama T, Tani Y, Masuda Y, Matsuki H, Tani M, Tanaka M.
    Hinyokika Kiyo; 2001 Jan; 47(1):11-4. PubMed ID: 11235214
    [Abstract] [Full Text] [Related]

  • 30. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A, Simşek F, Ilker Y, Türkeri L, Ercan H.
    Int Urol Nephrol; 1993 Jan; 25(3):271-8. PubMed ID: 7693607
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS, Ayala G, Aguilar L, Mai WY, Timme TL, Vlachaki MT, Miles B, Kadmon D, Wheeler T, Caillouet J, Davis M, Carpenter LS, Lu HH, Chiu JK, Woo SY, Thompson T, Aguilar-Cordova E, Butler EB.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1520-9. PubMed ID: 15050332
    [Abstract] [Full Text] [Related]

  • 35. Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques.
    Svanholm H, Hørder M.
    Scand J Urol Nephrol Suppl; 1988 Apr 01; 107():65-70. PubMed ID: 2453920
    [Abstract] [Full Text] [Related]

  • 36. Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and temperature monitoring--A one year follow-up.
    Lee F, Bahn DK, McHugh TA, Kumar AA, Badalament RA.
    Anticancer Res; 1997 Apr 01; 17(3A):1511-5. PubMed ID: 9179188
    [Abstract] [Full Text] [Related]

  • 37. Prognostic value of serial tissue prostate-specific antigen measurements during different hormonal treatments in prostate cancer patients.
    Grande M, Carlström K, Rozell BL, Stege R, Pousette A.
    Clin Cancer Res; 2000 May 01; 6(5):1790-5. PubMed ID: 10815899
    [Abstract] [Full Text] [Related]

  • 38. [Discrepancy between the serum levels of gamma seminoprotein and prostate-specific antigen in patients with prostatic neoplasms. Both true or either untrue].
    Fujino A, Mukai N, Kawakami T, Yokoyama E, Mashimo S, Endo T, Ishibashi A, Koshiba K, Aoki Y, Itoh H.
    Nihon Hinyokika Gakkai Zasshi; 1991 Apr 01; 82(4):541-50. PubMed ID: 1711133
    [Abstract] [Full Text] [Related]

  • 39. Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival.
    Cheville JC, Tindall D, Boelter C, Jenkins R, Lohse CM, Pankratz VS, Sebo TJ, Davis B, Blute ML.
    Cancer; 2002 Sep 01; 95(5):1028-36. PubMed ID: 12209687
    [Abstract] [Full Text] [Related]

  • 40. Cryosurgical ablation of the prostate: high risk patient outcomes.
    Prepelica KL, Okeke Z, Murphy A, Katz AE.
    Cancer; 2005 Apr 15; 103(8):1625-30. PubMed ID: 15747374
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.